Bogle Investment Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-409,679
| Closed | -$4.96M | – | 300 |
|
|
2017
Q2 | $4.96M | Buy |
409,679
+200,898
| +96% | +$2.43M | 0.36% | 107 |
|
|
2017
Q1 | $2.68M | Buy |
+208,781
| New | +$2.68M | 0.19% | 134 |
|
|
2016
Q1 | – | Sell |
-377,801
| Closed | -$3.95M | – | 396 |
|
|
2015
Q4 | $3.95M | Buy |
377,801
+161,433
| +75% | +$1.69M | 0.28% | 115 |
|
|
2015
Q3 | $1.45M | Buy |
216,368
+100,989
| +88% | +$675K | 0.1% | 229 |
|
|
2015
Q2 | $775K | Buy |
115,379
+83,430
| +261% | +$560K | 0.06% | 284 |
|
|
2015
Q1 | $216K | Buy |
+31,949
| New | +$216K | 0.01% | 330 |
|
|
2014
Q4 | – | Sell |
-319,647
| Closed | -$1.13M | – | 366 |
|
|
2014
Q3 | $1.13M | Sell |
319,647
-233,361
| -42% | -$821K | 0.07% | 236 |
|
|
2014
Q2 | $2.64M | Buy |
553,008
+198,828
| +56% | +$950K | 0.18% | 153 |
|
|
2014
Q1 | $3.36M | Buy |
+354,180
| New | +$3.36M | 0.23% | 143 |
|
|
2013
Q4 | – | Sell |
-447,035
| Closed | -$3.38M | – | 311 |
|
|
2013
Q3 | $3.38M | Buy |
+447,035
| New | +$3.38M | 0.34% | 111 |
|